|
A
Randomized, Phase III Study of Standard
Dosing versus Longer Dosing Interval of
Zoledronic Acid in Metastatic Cancer
(No Drugs Provided)
CALGB 70604
(MBMC Contact: Diana Christian
314-996-5888)
Click
For Consent
***
Prospective Observational Study of
the Incidence of Osteonecrosis of the
Jaw in Cancer Patients with Bone
Metastases Receiving Zoledronic Acid
(No Drugs Provided)
SWOG 0702
(MBMC Contact: Diana Christian
314-996-5888)
Click
For Consent
***
***Available
through CTSU
Next
→
|